Home
PENN Medicine News: Inhibiting Cholesterol-Associated Protein Reduces High-Risk Blockages in... Print E-mail
Monday, 22 September 2008
PHILADELPHIA ? Using the drug darapladib, researchers at the University of Pennsylvania School of Medicine and colleagues have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes.
Read more
Related news items:

 
< Prev   Next >